Home » Cardium Files 510(k) for ExcellagenXL Topical Gel and Flowable Collagen
Cardium Files 510(k) for ExcellagenXL Topical Gel and Flowable Collagen
Cardium Therapeutics announced Thursday that its wholly-owned
subsidiary, Tissue Repair Company, submitted a 510(k) premarket notification filing with the U.S. FDA seeking marketing clearance of its Excellagen product
candidate based on positive data from the Company’s recently
completed Phase 2b Matrix clinical study.
StreetInsider
StreetInsider
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May